April 27, 2026Open Access

From Efficacy to Effectiveness: When Proven Therapies Fail

Key Points

Key points are not available for this paper at this time.

Expert Takes1 quote

“There is no shortage of efficacious therapies that reduce cardiovascular risk. What is lacking, however, are effective mechanisms to bring these therapies to patients.”

TCTMDView source

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

McClintick et al. (Wed,) studied this question.

synapsesocial.com/papers/69efd2dab8a53e2a171bc9a6 — DOI: https://doi.org/10.1161/circoutcomes.126.013483

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Discontinuation of Statins in Routine Care Settings· 2013 · 537 citations
The worldwide trend in diabetes awareness, treatment, and control from 1985 to 2022: a systematic review and meta-analysis of 233 population-representative studies· 2024 · 25 citations
Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association· 2022 · 2,510 citations
Closing the Gap in Global Disparities in Hypertension Control· 2025 · 24 citations
System-Level Factors and Time Spent on Electronic Health Records by Primary Care Physicians· 2023 · 54 citations

Expert Takes

“1 expert quote

Authors

Daniel McClintick

Susan Cheng

Joseph E. Ebinger

Cardiac Imaging

Actions

Institutions

Cedars-Sinai Medical Center

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

From Efficacy to Effectiveness: When Proven Therapies Fail

Key Points

Expert Takes1 quote

Citation Network

Connected Papers

Discussion

Cite this study

Also consider

Expert Takes

Authors

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Also consider